Trulieve Cannabis Corp.
TRLV | NYSE
$10.28
-$0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM ET
$10.40
+$0.12 (+1.17%)
Pre-market:
Nov 2, 2026, 7:31 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 |
|---|---|---|---|---|---|
Revenue | 270.95M | 286.75M | 293.15M | 288.19M | 302.09M |
Cost of Revenue | 108.66M | 116.67M | 117.98M | 118.33M | 119.16M |
Gross Profit | 162.29M | 170.08M | 175.17M | 169.86M | 182.93M |
Operating Income | -370.52M | 35.44M | 19.44M | 41.38M | 52.38M |
Interest Income | 3.06M | 2.68M | 3.42M | 4.39M | 3.64M |
Pretax Income | -383.4M | 25.22M | 2.94M | 29.3M | 38.9M |
Net Income | -406.06M | 2.41M | -42.9M | -26.84M | -13.78M |
Selling & General & Admin | 101.77M | 104.9M | 126.31M | 99.02M | 101.12M |
Research & Development | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 431.05M | 29.74M | 29.42M | 29.46M | 29.43M |
Operating Expenses | 532.81M | 134.64M | 155.73M | 128.48M | 130.54M |
Interest Expense | 12.76M | 13.32M | 14.68M | 16.09M | 16.39M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 641.48M | 251.31M | 273.71M | 246.81M | 249.7M |
Income Tax Expense | 21.97M | 21.86M | 47.89M | 53.04M | 54.72M |
Shares Outstanding (Basic) | 192.71M | 192.54M | 191.7M | 191.2M | 191.2M |
Shares Outstanding (Diluted) | 192.71M | 197.76M | 191.7M | 191.2M | 191.2M |
EPS (Basic) | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 |
EPS (Diluted) | -2.10 | 0.01 | -0.22 | -0.14 | -0.07 |
EBITDA | -370.64M | 82.27M | 61.29M | 88.79M | 98.45M |
EBIT | -370.64M | 38.54M | 17.62M | 45.39M | 55.3M |
Depreciation & Amortization | n/a | 43.73M | 43.67M | 43.41M | 43.15M |
Add to Watchlist
Select watchlists to add or remove TRLV